Sarcoidosis

  • J. P. LynchIII
  • E. A. Kazerooni
Chapter

Abstract

Sarcoidosis is a poorly understood granulomatous disease that involves the lung and intrathoracic lymph nodes in more than 90% of patients (1–10). However, multisystemic involvement is characteristic and virtually any organ can be affected (3,4,8–10). Skin, eye, and peripheral lymph nodes are each involved in 20–30% of patients (3,7). Clinically significant involvement of spleen, liver, heart, central nervous system, bone, and kidney occurs in 2–7% of patients (3,4,7). Asymptomatic involvement of these organs is far more common (3,4,7). This review focuses on intrathoracic manifestations of sarcoidosis, and only briefly discusses a few specific extrapulmonary manifestations that may be of relevance to radiologists. A comprehensive review of extrapulmonary manifestations of sarcoidosis is presented elsewhere (3).

Keywords

Human Leukocyte Antigen Chest Radiograph Idiopathic Pulmonary Fibrosis Respir Crit Cardiac Sarcoidosis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Lynch JP, III, Kazerooni EA, Gay SE (1997) Pulmonary sarcoidosis. Clin Chest Med 18:755–85.PubMedGoogle Scholar
  2. 2.
    Lynch JP, III (1997) Pulmonary sarcoidosis: Current concepts and controversies. Comprehen Ther 23:197–210.Google Scholar
  3. 3.
    Lynch JP, II, Baughman RP, Sharma O (1998) Extrapulmonary sarcoidosis. Semin Respir Infect 13:229–254.PubMedGoogle Scholar
  4. 4.
    American Thoracic Society (1999) Statement on sarcoidosis. Am J Respir Crit Care Med 160:736–755.Google Scholar
  5. 5.
    Johns C, Michèle T (1999) The clinical management of sarcoidosis. Medicine 78:65–111.PubMedGoogle Scholar
  6. 6.
    Lynch JP, III, Strieter R (1991) Sarcoidosis. In Lynch, JP III, DeRemee R (eds) Immunologically mediated pulmonary disorders, JB Lippincott, Philadelphia, pp 189–216.Google Scholar
  7. 7.
    Newman LS, Rose CS, Maier LA (1997) Sarcoidosis. N Engl J Med 336:1224–1234.PubMedGoogle Scholar
  8. 8.
    Mayock RL, Bertrand P, Morrison CE, et al. (1963) Manifestations of sarcoidosis: Analysis of 145 patients, with a review of nine series selected from the literature. Am J Med 35:67–89PubMedGoogle Scholar
  9. 9.
    Longcope WT, Frieman DG (1952) A study of sarcoidosis based on a combined investigation of 160 cases including 30 autopsies from the Johns Hopkins Hospital and Massachusetts General Hospital. Medicine (Baltimore) 31:1–132Google Scholar
  10. 10.
    Siltzbach L, James D, Neville E, et al. (1974) Course and prognosis of sarcoidosis around the world. Am J Med 57:847–852PubMedGoogle Scholar
  11. 11.
    Rybicki BA, Major M, Popovich J Jr, et al. (1997) Racial differences in sarcoidosis incidence: A 5-year study in a health maintenance organization. Am J Epidemiol 145:234–241PubMedGoogle Scholar
  12. 12.
    Rybicki BA, Maliarik MJ, Major M, et al. (1998) Epidemiology, demographics, and genetics of sarcoidosis. Semin Respir Infect 13:166–173PubMedGoogle Scholar
  13. 13.
    Hosoda Y, Yamaguchi M, Hiraga Y (1997) Global epidemiology of sarcoidosis. What story do prevalence and incidence tell us? Clin Chest Med 18:681–694PubMedGoogle Scholar
  14. 14.
    Henke C, Henke G, Elveback L, et al. (1986) The epidemiology of sarcoidosis in Rochester, Minnesota: A population-based study of incidence and survival. Am J Epidemiol 123:840–845PubMedGoogle Scholar
  15. 15.
    Hillerdal G, Nou E, Osterman K, et al. (1984) Sarcoidosis: Epidemiology and prognosis. A 15 year European study. Am Rev Respir Dis 130:29–32PubMedGoogle Scholar
  16. 16.
    Mana J, Badrinas F, Morera J, et al. (1992) Sarcoidosis in Spain. Sarcoidosis 9:118–122PubMedGoogle Scholar
  17. 17.
    Fazzi P, Solfanelli S, Di Pede F, et al. (1992) Sarcoidosis in Tuscany. A preliminary report. Sarcoidosis 9:123–126PubMedGoogle Scholar
  18. 18.
    Yamaguchi M, Hosoda Y, Sasaki R, et al. (1989) Epidemiological study on sarcoidosis in Japan. Recent trends in incidence and prevalence rates and changes in epidemiological features. Sarcoidosis 6:138–146PubMedGoogle Scholar
  19. 19.
    Tellier P, Paycha F, Antony I, et al. (1988) Reversibility by dipyridamole of thallium-201 myocardial scan defects in patients with sarcoidosis. Am J Med 85:189–193PubMedGoogle Scholar
  20. 20.
    Fite E, Mana J, Alsina JM, et al. (1997) Sarcoidosis: The chest radiograph screening of familial contacts. Respiration 63:160–163Google Scholar
  21. 21.
    Martinetti M, Tinelli C, Kolek V, et al. (1995) “The sarcoidosis map”: A joint survey of clinical and immunogenetic findings in two European countries. Am J Respir Crit Care Med 152:557–564PubMedGoogle Scholar
  22. 22.
    Newman LS (1998) Metals that cause sarcoidosis. Semin Respir Infect 13:212–220PubMedGoogle Scholar
  23. 23.
    Hance AJ (1998) The role of mycobacteria in the pathogenesis of sarcoidosis. Semin Respir Infect 13:197–205PubMedGoogle Scholar
  24. 24.
    Moller DR (1997) Etiology of sarcoidosis. Clin Chest Med 18:695–706PubMedGoogle Scholar
  25. 25.
    Teirstein AS (1998) Kyeim antigen: What does it tell us about causation of sarcoidosis? Semin Respir Infect 13:206–211PubMedGoogle Scholar
  26. 26.
    Moller DR (1999) Cells and cytokines involved in the pathogenesis of sarcoidosis. Sarcoidosis Vase Diffuse Lung Dis 16:24–31Google Scholar
  27. 27.
    Agostini S, Semenzato G (1998) Cytokines in sarcoidosis. Semin Respir Infect, 13:184–196PubMedGoogle Scholar
  28. 28.
    Muller-Quernheim J (1998) Serum markers for the staging of disease activity of sarcoidosis and other interstitial lung diseases of unknown etiology. Sarcoidosis Vase Diffuse Lung Dis 15:22–37Google Scholar
  29. 29.
    Moller DR (1998) Involvment of T cells and alterations of T cell receptors in sarcoidosis. Semin Respir Infect 13:174–183PubMedGoogle Scholar
  30. 30.
    Colby TV, Carrington CB (1995) Infiltrative lung disease. In: Thurlbeck WM (ed) Pathology of the lung, 2nd edn. Thieme Medical Publishers, New York, pp 589–738Google Scholar
  31. 31.
    Rosen Y, Moon S, Hyang C, et al. (1977) Granulomatous pulmonary arteritis in sarcoidosis. Arch Pathol Lab Med 101:170–174PubMedGoogle Scholar
  32. 32.
    Carrington C, Gaensler E, Mikus J, et al. (1976) Structure and function in sarcoidosis. Ann NY Acad Sei 278:265–283Google Scholar
  33. 33.
    Nishimura K, Itoh H, Kitaichi M, et al. (1995) CT and pathological correlation of pulmonary sarcoidosis. Semin Ultrasound CT MR 16:361–370PubMedGoogle Scholar
  34. 34.
    Reich JM, Browns MC, O’Connor EA, et al. (1998) Mediastinoscopy in patients with presumptive stage I sarcoidosis. Chest 113: 147–153PubMedGoogle Scholar
  35. 35.
    Armstrong J, Radke J, Kvale P, et al. (1981) Endoscopic findings in sarcoidosis. Characteristics and correlation with radiographic staging and bronchial mucosal biopsy yield. Ann Otol 90:339–343Google Scholar
  36. 36.
    Koerner S, Sakowitz A, Appelman R, et al. (1975) Transbronchial lung biopsy for the diagnosis of sarcoidosis. N Engl J Med 293:268–270PubMedGoogle Scholar
  37. 37.
    Gilman M, Wang K (1980) Transbronchial lung biopsy in sarcoidosis: An approach to determine the optimal number of biopsies. Am Rev Respir Dis 122:721–724PubMedGoogle Scholar
  38. 38.
    Koontz C, Joyner L, Nelson R (1976) Transbronchial lung biopsy via the fiberoptic bronchoscope in sarcoidosis. Ann Intern Med 85:64–66Google Scholar
  39. 39.
    Roethe R, Byrd R, Hafermann D (1980) Transbronchoscopic lung biopsy in sarcoidosis: Optimal number and sites for diagnosis. Chest 77:400–402PubMedGoogle Scholar
  40. 40.
    Poe R, Israel R, Utell M, et al. (1979) Probability of a positive transbronchial lung biopsy result in sarcoidosis. Arch Intern Med 139:761–763PubMedGoogle Scholar
  41. 41.
    Mitchell D, Mitchell D, Emerson C (1980) Transbronchial lung biopsy through fiberoptic bronchoscope in diagnosis of sarcoidosis. Br Med J 280:679–681PubMedGoogle Scholar
  42. 42.
    Morales C, Patefield A, Strollo P-J, et al. (1994) Flexible trans-bronchial needle aspiration in the diagnosis of sarcoidosis. Chest 6:709–711Google Scholar
  43. 43.
    Pauli G, Pelletier A, Bohner C, et al. (1984) Transbronchial needle aspiration in the diagnosis of sarcoidosis. Chest 85:482–484PubMedGoogle Scholar
  44. 44.
    Wang KP, Fuenning C, Johns CJ, et al. (1989) Flexible trans-bronchial needle aspiration for the diagnosis of sarcoidosis. Ann Otol Rhinol Laryngol 98:298–300PubMedGoogle Scholar
  45. 45.
    Winterbauer R, Lemmert J, Selland M, et al. (1993) Bronchoalveolar lavage cell profiles in the diagnosis of sarcoidosis. Chest 104:352–361PubMedGoogle Scholar
  46. 46.
    Bjermer L, Rosenhall L, Angstrom T, et al. (1988) Predictive value of bronchoalveolar lavage cell analysis in sarcoidosis. Thorax 43:284–288PubMedGoogle Scholar
  47. 47.
    Vernon S (1985) Nodular pulmonary sarcoidosis: Diagnosis with fine needle aspiration biopsy. Acta Cytol 29:473–476PubMedGoogle Scholar
  48. 48.
    Aisner S, Gupta P, Frost J (1977) Sputum cytology in pulmonary sarcoidosis. Acta Cytol 21:394–398PubMedGoogle Scholar
  49. 49.
    Zaman S, Elshami A, Gupta P (1995) Bronchalveolar cytology in pulmonary sarcoidosis. Acta Cytol 39:1117–1123PubMedGoogle Scholar
  50. 50.
    Hendricks MV, Crosby JH, Davis WB (1999) Bronchoalveolar lavage fluid granulomas in a case of severe sarcoidosis. Am J Respir Crit Care Med 160:730–731PubMedGoogle Scholar
  51. 51.
    Neville E, Walker A, James D (1983) Prognostic factors predicting the outcome of sarcoidosis: An analysis of 818 patients. Quart J Med 208:525–533Google Scholar
  52. 52.
    Goldstein RA, Israel HL, Becker KL, et al. (1971) The infrequency of hypercalcemia in sarcoidosis. Am J Med 51:21–30PubMedGoogle Scholar
  53. 53.
    Sharma OP (1996) Vitamin D, calcium, and sarcoidosis. Chest 109:535–539PubMedGoogle Scholar
  54. 54.
    Niimi T, Tomita H, Sato S, et al. (1999) Vitamin D receptor gene polymorphism in patients with sarcoidosis. Am J Respir Crit Care Med 160:1107–1109PubMedGoogle Scholar
  55. 55.
    Costabel U, Teschler H (1997) Biochemical changes in sarcoidosis. Clin Chest Med 18:827–842PubMedGoogle Scholar
  56. 56.
    Meyrier A, Valeyre D, Bouillon R, et al. (1985) Resorptive versus absorptive hypercalciuria in sarcoidosis: Correlations with 25-hydroxy vitamin D3 and 1,25-dihydroxy vitamin D3 and parameters of disease activity. Q J Med 54:269–281PubMedGoogle Scholar
  57. 57.
    Winterbauer RH, Belie N, Moores KD (1973) Clinical interpretation of bilateral hilar adenopathy. Ann Intern Med 78:65–71.PubMedGoogle Scholar
  58. 58.
    Baughman R, Lower E, Lynch J III (1994) Treatment modalities for sarcoidosis. Clin Pulm Med 1:223–231.Google Scholar
  59. 59.
    Scadding J (1961) Prognosis of intrathoracic sarcoidosis in England: A review of 136 cases after five years’ observation. Br Med J 2:1165–1172.PubMedGoogle Scholar
  60. 60.
    Romer F (1982) Presentation of sarcoidosis and outcome of pulmonary changes. A review of 243 patients followed for up to 10 years. Dan Med Bull 29:27–32.PubMedGoogle Scholar
  61. 61.
    Lavergne F, Clerici C, Sadoun D, et al. (1999) Airway obstruction in bronchial sarcoidosis: Outcome with treatment. Chest 116: 1194–1199.PubMedGoogle Scholar
  62. 62.
    Siltzbach L (1967) Sarcoidosis: Clinical features and management. Med Clin North Am 51:483–502.PubMedGoogle Scholar
  63. 63.
    Reich J, Johnson R (1985) Course and prognosis of sarcoidosis in a nonreferral setting: Analysis of 86 patients observed for 10 years. Am J Med 89:61.Google Scholar
  64. 64.
    Thomas P, Hunninghake G (1987) Current concepts of the pathogenesis of sarcoidosis. Am Rev Respir Dis 135:747–760.PubMedGoogle Scholar
  65. 65.
    Takada K, Ina Y, Noda M, et al. (1993) The clinical course and prognosis of patients with severe, moderate, or mild sarcoidosis. J Clin Epidemiol 46:359–366.PubMedGoogle Scholar
  66. 66.
    Sharma O (1993) Pulmonary sarcoidosis and corticosteroids. Am Rev Respir Dis 147:1598–1600.PubMedGoogle Scholar
  67. 67.
    Sharma OP (1997) Neurosarcoidosis: A personal perspective based on the study of 37 patients. Chest 112:220–228.PubMedGoogle Scholar
  68. 68.
    Gideon N, Mannino D (1996) Sarcoidosis mortality in the United States, 1979–1981: An analysis of multiple-cause mortality data. Am J Med 100:423–427.PubMedGoogle Scholar
  69. 69.
    Huang C, Heurich A, Sutton A, Lyons H (1981) Mortality in sarcoidosis: A changing pattern of the causes of death. Eur J Respir Dis 62:231–238.PubMedGoogle Scholar
  70. 70.
    Perry A, Vuitch F (1995) Causes of death in patients with sarcoidosis. A morphologic study of 38 autopsies with clinicopathologic correlations. Arch Pathol Lab Med 119:167–172.PubMedGoogle Scholar
  71. 71.
    Yamamoto M, Kosuda T, Yanagawa H, et al. (1977) Long-term follow-up in sarcoidosis in Japan. Z Erk Atmungsorgane 149:191–196.Google Scholar
  72. 72.
    Israel H, Karlin P, Menduke H, et al. (1986) Factors affecting outcome of sarcoidosis: influence of race extrathoracic involvement, and initial radiologic lung lesions. Ann NY Acad Sei 465:395–406.Google Scholar
  73. 73.
    Gottlieb JE, Israel HL, Steiner RM, et al. (1997) Outcome in sarcoidosis: The relationship of relapse to corticosteroid therapy. Chest 111:623–631.PubMedGoogle Scholar
  74. 74.
    Johns C J, Schonfeld SA, Scott PP, et al. (1986) Longitudinal study of chronic sarcoidosis with low-dose maintenance corticosteroid therapy: Outcome and complications. Ann NY Acad Sei 465: 702–712.Google Scholar
  75. 75.
    Baughman RP, Lower EE (1997) Steroid-sparing alternative treatments for sarcoidosis. Clin Chest Med 18:853–864.PubMedGoogle Scholar
  76. 76.
    Iwai K, Takemura T, Matsui Y, et al. (1993) Pathological studies on sarcoidosis autopy: II. Early change, mode of progression and death pattern. Acta Pathol Jpn 43:377–385.PubMedGoogle Scholar
  77. 77.
    Bechtel J, Starr T, III, Dantzker D, et al. (1981) Airway hyperactivity in patients with sarcoidosis. Am Rev Respir Dis 124:759–761.PubMedGoogle Scholar
  78. 78.
    Highland KB, Retalis P, Coppage L, et al. (1997) Is there anatomic explanation for chest pain in patients with pulmonary sarcoidosis. South Med J 90:911–941.PubMedGoogle Scholar
  79. 79.
    Sharma O, Badr A (1994) Sarcoidosis: Diagnosis, staging, and newer diagnostic modalities. Clin Pulm Med 1:18–26.Google Scholar
  80. 80.
    Scadding J, Mitchell D (1985) Sarcoidosis, 2nd edn. Chapman & Hall, London.Google Scholar
  81. 81.
    Chiles C, Putnam C (1992) Pulmonary sarcoidosis. Semin Respir Med 13:345–357.Google Scholar
  82. 82.
    Kirks D, McCormick V, Greenspan R (1973) Pulmonary sarcoidosis. Roentgenologic analysis of 150 patients. AJR Radium Ther Nucl Med 117:777–786.Google Scholar
  83. 83.
    Brauner M, Lenoir S, Grenier P, et al. (1992) Pulmonary sarcoidosis. CT assessment of reversibility. Radiology 182:349–355.PubMedGoogle Scholar
  84. 84.
    James D, Carstairs L, Trowell J, et al. (1967) Treatment of sarcoidosis: Report of a controlled therapeutic trial. Lancet 2:526–528.PubMedGoogle Scholar
  85. 85.
    Brauner M, Grenier P, Mompoint D, et al. (1989) Pulmonary sarcoidosis: Evaluation with high-resolution CT. Radiology 172:467–471.PubMedGoogle Scholar
  86. 86.
    Hamper U, Fishman E, Khouri N, et al. (1986) Typical and atypical pulmonary sarcoidosis. J Comput Assist Tomogr 10:928–936.PubMedGoogle Scholar
  87. 87.
    Bergin C, Bell D, Coblentz C, et al. (1989) Sarcoidosis: Correlation of pulmonary parenchymal pattern at CT with results of pulmonary function tests. Radiology 171:619–624.PubMedGoogle Scholar
  88. 88.
    Mana J, Tierstein A, Mendelson D, et al. (1995) Excessive thoracic computed tomographic scanning in sarcoidosis. Thorax 50: 1264–1266.PubMedGoogle Scholar
  89. 89.
    Sieder L, Horton E (1990) Hilar and mediastinal adenopathy in sarcoidosis as detected by computed tomography. J Thorac Imaging 5:77–80.Google Scholar
  90. 90.
    Kuhlman JE, Fishman EK, Hamper UM, et al. (1989) The computed tomographic spectrum of sarcoidosis. RadioGraphics 9:449–466.PubMedGoogle Scholar
  91. 91.
    Rosseel B, Vierendeells T, Noppen M, et al. (1986) Posterior mediastinal sarcoidosis. Chest 90:462–464.PubMedGoogle Scholar
  92. 92.
    Kutty C, Varkey B (1982) Sarcoidosis presenting with posterior mediastinal lymphadenopathy. Postgrad Med 71:64–66.PubMedGoogle Scholar
  93. 93.
    Schabel S, Foote G, McKee K (1978) Posterior lymphadenopathy in sarcoidosis. Radiology 129:591–593.PubMedGoogle Scholar
  94. 94.
    Kent DC (1965) Recurrent unilateral hilar lymph node enlargement in sarcoidosis. Am Rev Respir Dis 91:272.PubMedGoogle Scholar
  95. 95.
    Spann R, Rosenow E, III, DeRemee R, et al. (1971) Unilateral hilar or paratracheal adenopathy in sarcoidosis: a study of 38 cases. AJR Rad Ther Nuc Med 126:296–299.Google Scholar
  96. 96.
    Rockoff S, Rohatgi P (1985) Unusual manifestations of thoracic sarcoidosis. AJR 144:513–528.PubMedGoogle Scholar
  97. 97.
    Israel H, Sones M, Roy R, et al. (1961) The occurrence of intrathoracic calcification in sarcoidosis. Am Rev Respir Dis 84:1–11.PubMedGoogle Scholar
  98. 98.
    Israel H, Lenchner G, Steiner R (1981) Late development of mediastinal calcification in sarcoidosis. Am Rev Respir Dis 124:302–305.PubMedGoogle Scholar
  99. 99.
    McLoud T, Putnam C, Pascual R (1974) Eggshell calcification with systemic sarcoidosis. Chest 66:515–517.PubMedGoogle Scholar
  100. 100.
    Murdoch J, Müller N (1992) Pulmonary sarcoidosis: changes on follow-up CT examination. AJR 159:473–477.PubMedGoogle Scholar
  101. 101.
    Gawne-Cain ML, Hansell DM (1996) The pattern and distribution of calcified mediastinal lymph nodes in sarcoidosis and tuberculosis. Clinical Radiology 51:263–267.PubMedGoogle Scholar
  102. 102.
    Gross BH, Schneider HJ, Proto AV (1980) Eggshell calcification of lymph nodes: An update. AJR 135:1265–1268.PubMedGoogle Scholar
  103. 103.
    Müller N, Kullnig P, Miller R (1989) The CT findings in pulmonary sarcoidosis: Analysis of 25 patients. AJR 152:1179–1182.PubMedGoogle Scholar
  104. 104.
    Wells A (1998) High resolution computed tomography in sarcoidosis: A clinical perspective. Sarcoidosis Vase Diffuse Lung Dis 15:140–146.Google Scholar
  105. 105.
    Stone DJ, Schwartz A (1966) A long-term study of sarcoid and its modification by steroid therapy. Lung function and other factors in prognosis. Am J Med 41:528–540.PubMedGoogle Scholar
  106. 106.
    Grenier P, Brauner M, Valeyre D (1999) Computed tomography in the assessment of diffuse lung disease. Sarcoidosis Vase Diffuse Lung Dis 16:47–56.Google Scholar
  107. 107.
    Traill ZC, Maskell GF, Gleeson FV (1997) High-resolution CT findings of pulmonary sarcoidosis. AJR 168:1557–1560.PubMedGoogle Scholar
  108. 108.
    Battesti J, Saumon G, Valeyre D, et al. (1982) Pulmonary sarcoidosis with an alveolar radiographic pattern. Thorax 37:448–452.PubMedGoogle Scholar
  109. 109.
    Mathieson JR, Mayo JR, Staples CA, et al. (1989) Chronic diffuse infiltrative lung disease: Comparison of diagnostic accuracy of CT and chest radiography. Radiology 171:111–116PubMedGoogle Scholar
  110. 110.
    McLoud T, Epler G, Gaensler E, et al. (1982) A radiographic classification for sarcoidosis: Physiologic correlation. Invest Radiol 17:129–138PubMedGoogle Scholar
  111. 111.
    Tazi A, Desfemmes-Baleyte T, Soler P, et al. (1994) Pulmonary sarcoidosis with a diffuse ground glass pattern on the chest radiograph. Thorax 49:793–797PubMedGoogle Scholar
  112. 112.
    Scadding JG (1970) The late stages of pulmonary sarcoidosis. Postgrad Med J 46:530–536PubMedGoogle Scholar
  113. 113.
    Kazerooni EA, Jackson C, Cascade PN (1994) Sarcoidosis: Recurrence of primary disease in transplanted lungs. Radiology 192:461–464PubMedGoogle Scholar
  114. 114.
    Pacheo Y, Maréchal C, Maréchal F, et al. (1985) Azathioprine treatment of chronic pulmonary sarcoidosis. Sarcoidosis 2:107–113Google Scholar
  115. 115.
    Zar H, Cole R (1995) Bullous emphysema occurring in pulmonary sarcoidosis. Respiration 62:290–293PubMedGoogle Scholar
  116. 116.
    Ichikawa Y, Fujimoto K, Shiraishi T, et al. (1994) Primary cavitary sarcoidosis: High resolution CT findings. AJR 163:745PubMedGoogle Scholar
  117. 117.
    Rohatgi P, Schwab L (1980) Primary acute pulmonary cavitation in sarcoidosis. AJR 134:1199–1203PubMedGoogle Scholar
  118. 118.
    Biem J, Hoffstein V (1991) Aggressive cavitary pulmonary sarcoidosis. Am Rev Respir Dis 143:428–430PubMedGoogle Scholar
  119. 119.
    Damuth TE, Bower JS, Cho K, et al. (1980) Major pulmonary artery stenosis causing pulmonary hypertension in sarcoidosis. Chest 78:888–891PubMedGoogle Scholar
  120. 120.
    Battesti J, Georges R, Basset F, et al. (1978) Chronic cor pulmonale in sarcoidosis. Thorax 33:76–84PubMedGoogle Scholar
  121. 121.
    Smith L, Lawrence J, Katzenstein A (1982) Vascular sarcoidosis: a rare cause of pulmonary hypertension. Am J Med Sei 285:38–44Google Scholar
  122. 122.
    Levine B, Saldana M, Hutter A (1971) Pulmonary hypertension is sarcoidosis. A case report of a rare but potentially treatable cause. Am Rev Respir Dis 103:413–417PubMedGoogle Scholar
  123. 123.
    Rodman D, Lindenfeld J (1990) Successful treatment of sarcoidosis-associated pulmonary hypertension with corticosteroids. Chest 97:500–502PubMedGoogle Scholar
  124. 124.
    Hietala S, Stinnett R, Faunce M, et al. (1977) Pulmonary artery narrowing in sarcoidosis. JAMA 237:572PubMedGoogle Scholar
  125. 125.
    Westcott J, DeGraff A (1973) Sarcoidosis, hilar adenopathy, and pulmonary artery narrowing. Radiology 108:585PubMedGoogle Scholar
  126. 126.
    Faunce HF, Ramsay GC, Sy W (1976) Protracted yet variable major pulmonary artery compression in sarcoidosis. Radiology 119: 313–314PubMedGoogle Scholar
  127. 127.
    Mangla A, Fisher J, Libby D, et al. (1985) Sarcoidosis: pulmonary hypertension and acquired peripheral pulmonary artery stenosis. Cathet Cardiovasc Diagn 11:69–74PubMedGoogle Scholar
  128. 128.
    Schowengerdt CG, Suyemeto R, Main FB (1960) Granulomatous and fibrosing mediastinitis. J Thorac Cardiovasc Surg 57:365–379Google Scholar
  129. 129.
    Javaheri S, Hales H (1980) Sarcoidosis: A cause of innominate vein obstruction and massive pleural effusion. Lung 157:81–85PubMedGoogle Scholar
  130. 130.
    Gordonson J, Trachtenberg S, Sargent E (1973) Superior vena cava obstruction due to sarcoidosis. Chest 63:292–293PubMedGoogle Scholar
  131. 131.
    Soskel N, Sharma O (1992) Pleural involvement in sarcoidosis: Case presentation and detailed review of the literature. Semin Respir Med 13:492–514Google Scholar
  132. 132.
    Brandstetter, Hansen D, Jarowski C, et al. (1981) Superior vena cava syndrome as the initial clinical manifestation of sarcoidosis. Heart Lung 10:101–104PubMedGoogle Scholar
  133. 133.
    Kinney E, Murthy R, Ascunce G, et al. (1980) Sarcoidosis: Rare case of superior vena caval obstruction. Penn Med 83:31Google Scholar
  134. 134.
    Radke JR, Kaplan H, Conway WA (1980) The significance of superior vena cava syndrome developing in a patient with sarcoidosis. Radiology 134:311–312PubMedGoogle Scholar
  135. 135.
    Schachter EN, Smith GJW, Cohen GS, et al. (1975) Pulmonary granulomas in a patient with pulmonary veno-occlusive disease. Chest 67:487–489PubMedGoogle Scholar
  136. 136.
    Hoffstein V, Ranganathan N, Mullen J (1986) Sarcoidosis simulating pulmonary veno-occlusive disease. Am Rev Respir Dis 134:809–811PubMedGoogle Scholar
  137. 137.
    Sharma O, Gordonson J (1975) Pleural effusion in sarcoidosis: Report of six cases. Thorax 30:95–101PubMedGoogle Scholar
  138. 138.
    Durand D, Dellinger A, Guerin C, et al. (1984) Pleural sarcoidosis: One case presenting with an eosinophilic effusion. Thorax 39:468–469PubMedGoogle Scholar
  139. 139.
    Beekman JF, Zimmet SM, Chun BK, et al. (1976) Spectrum of pleural involvement in sarcoidosis. Arch Intern Med 136:323–330PubMedGoogle Scholar
  140. 140.
    Nicholls A, Friend J, Legge J (1980) Sarcoid pleural effusion: Three cases and review of the literature. Thorax 35:277–281PubMedGoogle Scholar
  141. 141.
    Flammang d’Ortho M, Cadranel J, Milleron B, et al. (1990) Pleural, alveolar and blood T-lymphocyte subsets in pleuropulmonary sarcoidosis. Chest 98:782–783PubMedGoogle Scholar
  142. 142.
    Libshitz HI, Atkinson GW, Israel HL (1974) Pleural thickening as a manifestation of aspergillus superinfection. AJR Radium Ther Nucl Med 120:883–886Google Scholar
  143. 143.
    Aberg H, Bah M, Waters A (1966) Sarcoidosis complicated by chylothorax. Minnesota Med 49:1065–1070PubMedGoogle Scholar
  144. 144.
    Jarman P, Whyte M, Sabroe I, et al. (1995) Sarcoidosis presenting as chylothorax. Thorax 50:1324–1325PubMedGoogle Scholar
  145. 145.
    Cappell M, Friedman D, Mikhail N (1993) Chyloperitoneum associated with chronic severe sarcoidosis. Am J Gastroenterol 88:99–101PubMedGoogle Scholar
  146. 146.
    Haegeli A, Keller R (1981) Chylothorax bei Sarkoidose. Schweiz Med Wechenschr 111:125–128Google Scholar
  147. 147.
    Loughney E, Higgins BG (1997) Pleural sarcoidosis: A rare presentation. Thorax 5:200–201Google Scholar
  148. 148.
    Israel H, Lenchner G, Atkinson G (1982) Sarcoidosis and aspergilloma. The role of surgery. Chest 82:430–432PubMedGoogle Scholar
  149. 149.
    Jewkes J, Kay PH, Paneth M, et al. (1983) Pulmonary aspergilloma: Analysis of prognosis in relation to haemoptysis and survey of treatment. Thorax 38:572–578PubMedGoogle Scholar
  150. 150.
    Johns C (1982) Management of hemoptysis with pulmonary fungus balls in sarcoidosis. Chest 82:400–401Google Scholar
  151. 151.
    Kaplan J, Johns C (1979) Mycetomas in pulmonary sarcoidosis: Non-surgical management. Johns Hopkins Med J 145:157–161PubMedGoogle Scholar
  152. 152.
    Tomlinson J, Sahn S (1987) Aspergilloma in sarcoid and tuberculosis. Chest 92:505–508PubMedGoogle Scholar
  153. 153.
    Wollschlager C, Khan F (1984) Aspergillomas complicating sarcoidosis: A prospective study in 100 patients. Chest 86:585-588PubMedGoogle Scholar
  154. 154.
    Rumbak M, Köhler G, Eastrige C, et al. (1996) Topical treatment of life threatening haemoptysis from aspergillomas. Thorax 51:253–255PubMedGoogle Scholar
  155. 155.
    Hargis JL, Bone RC, Stewart J, et al. (1980) Intracavitary amphotericin B in the treatment of symptomatic pulmonary aspergillomas. Am J Med 68:389–394PubMedGoogle Scholar
  156. 156.
    Yamada H, Kohno S, Koga H, et al. (1993) Topical treatment of pulmonary aspergilloma by antifungals. Relationship between duration of the disease and efficacy of therapy. Chest 103:1421–1425PubMedGoogle Scholar
  157. 157.
    Jackson M, Flower CD, Shneerson JM (1993) Treatment of symptomatic pulmonary aspergillomas with intracavitary instillation of amphotericin B through an indwelling catheter. Thorax 48:928–930PubMedGoogle Scholar
  158. 158.
    Sharma O, Hewlett R, Gordonson J (1973) Nodular sarcoidosis: An unusual radiographic appearance. Chest 64:189–192PubMedGoogle Scholar
  159. 159.
    Rose R, Lee R, Costello P (1985) Solitary nodular sarcoidosis. Clin Radiol 36:589–592PubMedGoogle Scholar
  160. 160.
    Onal E, Lopata M, Lourenco R (1977) Nodular pulmonary sarcoidosis: Clinical, roentgenographic, and physiologic course in five patients. Chest 72:296–300PubMedGoogle Scholar
  161. 161.
    Romer F (1977) Sarcoidosis with large nodular lesions simulating pulmonary metastasis: An analysis of 126 cases of intrathoracic sarcoidosis. Scand J Respir Dis 58:11–16.PubMedGoogle Scholar
  162. 162.
    Kiyosawa K (1998) Sarcoidosis associated with multiple large pulmonary nodules. Respirology 4:372–376.Google Scholar
  163. 163.
    Liebow AA (1973) The J. Burns Amberson lecture-pulmonary angiitis and granulomatosis. Am Rev Respir Dis 108:1–18.PubMedGoogle Scholar
  164. 164.
    Gibbs A, Williams W, Kelland D (1987) Necrotizing sarcoid granulomatosis: A problem of identity. A study of 7 cases. Sarcoidosis 4:94–100.PubMedGoogle Scholar
  165. 165.
    Churg A, Carrington C, Gupta R (1979) Necrotizing sarcoid granulomatosis. Chest 76:406–413.PubMedGoogle Scholar
  166. 166.
    Churg A (1983) Pulmonary angiitis and granulomatosis revisited. Hum Pathol 14:868–883.PubMedGoogle Scholar
  167. 167.
    Saldana M (1978) Necrotizing sarcoid granulomatosis: Clinicopathologic observations in 24 patients. Lab Invest 38:364.Google Scholar
  168. 168.
    Chittock D, Joseph M, Patterson N, et al. (1994) Necrotizing sarcoid granulomatosis with pleural involvement: Clinical and radiographic features. Chest 106:672–676.PubMedGoogle Scholar
  169. 169.
    Niimi H, Hartman T, Müller N (1995) Necrotizing sarcoid granulomatosis: Computed tomography and pathologic findings. J Comput Assist Tomogr 19:920–923.PubMedGoogle Scholar
  170. 170.
    Hammar SP (1995) Granulomatous vasculitis. Semin Respir Infect 10:107–120.PubMedGoogle Scholar
  171. 171.
    Koss M, Hochholzer L, Geiger D, et al. (1980) Necrotizing sarcoidlike granulomatosis. Hum Pathol 11(Suppl):510–519.PubMedGoogle Scholar
  172. 172.
    Demicco W, Fanburg B (1982) Sarcoidosis presenting as a lobar or unilateral lung infiltrate. Clin Radiol 33:663–669.PubMedGoogle Scholar
  173. 173.
    Littner M, Schachter E, Putman C, et al. (1977) The clinical assessment of roentgenographically atypical pulmonary sarcoidosis. Am J Med 62:361–368.PubMedGoogle Scholar
  174. 174.
    Mendelson D, Norton K, Cohen B, et al. (1983) Bronchial compression: An unusual manifestation of sarcoidosis. J Comput Assist Tomogr 7:892–894.PubMedGoogle Scholar
  175. 175.
    Udwadia Z, Pilling J, Henkins P, et al. (1990) Bronchoscopic and bronchographic findings in 12 patients with sarcoidosis and severe or progressive airways obstruction. Thorax 45:272–275.PubMedGoogle Scholar
  176. 176.
    Westcott J, Noehren T (1973) Bronchial stenosis in chronic sarcoidosis. Chest 63:893–897.PubMedGoogle Scholar
  177. 177.
    Olsson T, Bjormtad-Pettersen H, et al. (1979) Bronchostenosis due to sarcoidosis. Chest 75:663–666.PubMedGoogle Scholar
  178. 178.
    DiBenedetto R, Ribaudo C (1966) Bronchopulmonary sarcoidosis. Am Rev Respir Dis 94:952–958.Google Scholar
  179. 179.
    Munt P (1973) Middle lobe atelectasis in sarcoidosis. Am Rev Respir Dis 108:357–360.PubMedGoogle Scholar
  180. 180.
    Lenique F, Brauner M, Grenier P, et al. (1995) CT assessment of bronchi in sarcoidosis: Endoscopic and pathologic correlations. Radiology 194:419–423.PubMedGoogle Scholar
  181. 181.
    Hadfield J, Page R, Flower C, et al. (1982) Localized airway narrowing in sarcoidosis. Thorax 37:443–447.PubMedGoogle Scholar
  182. 182.
    Brown K, Yeoh C, Saddekni S (1988) Balloon dilatation of the left main bronchus in sarcoidosis. AJR 150:553–554.PubMedGoogle Scholar
  183. 183.
    Niimi H, Kang EY, Kwong JS, et al. (1966) CT of chronic infiltrative lung disease: Prevalence of mediastinal lymphadenopathy. J Comput Assist Tomogr 20:305–308.Google Scholar
  184. 184.
    Rémy-Jardin M, Giraud F, Rémy J, et al. (1994) Pulmonary sarcoidosis: Role of CT in the evaluation of disease activity and functional impairment and in prognosis assessment. Radiology 191:675–680.PubMedGoogle Scholar
  185. 185.
    Kosmorsky GS, Meisler DM, Rice TW, et al. (1998) Chest computed tomography and mediastinoscopy in the diagnosis of sarcoidosis-assoicated uveitis. Am J Opthalmol 126:132–136.Google Scholar
  186. 186.
    Mana J, Gomez-Vaquero C, Montero A, et al. (1999) Lofgren’s syndrome revisited: A study of 186 patients. Am J Med 107:240–245.PubMedGoogle Scholar
  187. 187.
    Johkoh T, Ikezoe J, Takeuchi N, et al. (1992) CT findings in pseudoalveolar sarcoidosis. J Comput Assist Tomogr 16:904–907.PubMedGoogle Scholar
  188. 188.
    Rémy-Jardin M, Rémy J, Deffontaines C, et al. (1991) Assessment of diffuse infiltrative lung disease: Comparison of conventional CT and high-resolution CT. Radiology 181:157–162.PubMedGoogle Scholar
  189. 189.
    Lynch D, Webb W, Gamsu G, et al. (1989) Computed tomography in pulmonary sarcoidosis. J Comput Assist Tomogr 13:405–410.PubMedGoogle Scholar
  190. 190.
    Winterbauer R, Hutchinson J (1980) Use of pulmonary function tests in the management of sarcoidosis. Chest 78:640–647.PubMedGoogle Scholar
  191. 191.
    Bradvik I, Wollmer P, Blom-Bulow B, et al. (1991) Lung mechanics and gas exchange during exercise in pulmonary sarcoidosis. Chest 99:572–578.PubMedGoogle Scholar
  192. 192.
    Miller A, Brown L, Sloane M, et al. (1995) Cardiorespiratory responses to incremental excercise in sarcoidosis patients with normal spirometry. Chest 107:323–329.PubMedGoogle Scholar
  193. 193.
    Dunn T, Watters L, Hendrix C, et al. (1988) Gas exchange at a given degree of volume restriction is different in sarcoidosis and idiopathic pulmonary fibrosis. Am J Med Z 85:221–224.Google Scholar
  194. 194.
    Harrison B, Shaylor J, Stokes T (1991) Airflow limitation in sarcoidosis: A study of pulmonary function in 107 patients with newly diagnosed disease. Respir Med 85:59–64.PubMedGoogle Scholar
  195. 195.
    Levinson R, Metzger L, Standley N, et al. (1977) Airway function in sarcoidosis. Am J Med 62:215–222.Google Scholar
  196. 196.
    McCann B, Harrison B (1991) Bronchiolar narrowing and occlusion in sarcoidosis—correlation of pathology with physiology. Respir Med 85:65–67.PubMedGoogle Scholar
  197. 197.
    Nugent KM, Peterson MW, Jolies H, et al. (1989) Correlation of chest roentgenograms with pulmonary function and bronchoalve-olar lavage in interstitial lung disease. Chest 96:1224–1227.PubMedGoogle Scholar
  198. 198.
    Huang C, Heurich A, Rosen Y, et al. (1979) Pulmonary sarcoidosis: Roentgenographic, functional, and pathological correlation. Respiration 37:337–345.PubMedGoogle Scholar
  199. 199.
    ILO/UC (1972) 1971 International classification of radiographs of the pneumoconioses. Med Radiogr Photogr 48:67–76.Google Scholar
  200. 200.
    Müller N, Mawson J, Mathieson J, et al. (1989) Sarcoidosis: Correlation of extent of disease at CT with clinical, functional and radiographic findings. Radiology 171:613–618.PubMedGoogle Scholar
  201. 201.
    Israel HL, McComb BL (1991) Chlorambucil treatment of sarcoidosis. Sarcoidosis, 8:35–41.PubMedGoogle Scholar
  202. 202.
    Pasturenzi L, Martinetti M, Cuccia M, et al. (1993) HLA class I, II, and III polymorphism in Italian patients with sarcoidosis. The Pavia-Padova Sarcoidosis Study Group. Chest 104:1170–1175.PubMedGoogle Scholar
  203. 203.
    Lenhart K, Kolek V, Bartova A (1990) HLA antigens associated with sarcoidosis. Dis Markers 8:23–29.PubMedGoogle Scholar
  204. 204.
    Ina Y, Takada K, Yamamoto M, et al. (1989) HLA and sarcoidosis in the Japanese. Chest 95:1257–1261.PubMedGoogle Scholar
  205. 205.
    Raphael SA, Blau EB, Zhang WH, et al. (1993) Analysis of a large kindred with Blau syndrome for HLA, autoimmunity, and sarcoidosis. Am J Dis Child 147:842–848.PubMedGoogle Scholar
  206. 206.
    Gran JT, Böhmer E (1996) Acute sarcoid arthritis: A favorable outcome? A retrospective survey of 49 patients with review of the literature. Scand J Rheumatol 25:70–73.PubMedGoogle Scholar
  207. 207.
    Ward K, O’Connor C, Odium C, et al. (1989) Prognostic value of bronchoalveolar lavage in sarcoidosis: The critical influence of disease presentation. Thorax 44:6–412.PubMedGoogle Scholar
  208. 208.
    Glennas A, Kvien TK, Melby K, et al. (1995) Acute sarcoid arthritis: occurrence, seasonal onset, clinical features and outcome. Br J Rheumatol 34:45–50.PubMedGoogle Scholar
  209. 209.
    Chapelon C, Ziza JM, Piette JC, et al. (1990) Neurosarcoidosis: Signs, course and treatment in 35 confirmed cases. Medicine (Baltimore) 69:261–276.Google Scholar
  210. 210.
    Rohatgi PK (1992) Osseous sarcoidosis. Semin Respir Med 13:468–488.Google Scholar
  211. 211.
    DeRemee R, Offord K (1992) The treatment of pulmonary sarcoidosis: The house revisited. Sarcoidosis 9:17S–29S.Google Scholar
  212. 212.
    Baughman RP, Sharma OP, Lynch JP, III (1998) Sarcoidosis: Is therapy effective? Semin Respir Infect 13:255–273.PubMedGoogle Scholar
  213. 213.
    Hunninghake G, Gilbert S, Pueringer R, et al. (1994) Outcome of the treatment for sarcoidosis. Am J Respir Crit Care Med 149:893–898.PubMedGoogle Scholar
  214. 214.
    Gibson G, Prescott R, Muers M, et al. (1996) The British Thoracic Society Sarcoidosis Study: Effects of long term corticosteroid treatment. Thorax 51:238–247.PubMedGoogle Scholar
  215. 215.
    Ziegenhagen MW, Benner UK, Zissel G, et al. (1997) Sarcoidosis: TNF-alpha release from alveolar macrophages and serum level of sIL-2R are prognostic markers. Am J Respir Crit Care Med 156:1586–1592.PubMedGoogle Scholar
  216. 216.
    Sulavik S, Spencer R, Palestro C, et al. (1993) Specificity and sensitivity of distinctive chest radiographic and/or Ga67 images in the noninvasive diagnosis of sarcoidosis. Chest 103:403–409.PubMedGoogle Scholar
  217. 217.
    Mana JN (1997) Nuclear imaging 67gallium, 201thallium, 18F-labeled fluoro-2-deoxy-D-glucose positron emission tomography. Clin Chest Med 18:799–811.PubMedGoogle Scholar
  218. 218.
    Jones C, Lake R, Wijeyekoon J, et al. (1996) Oligoclonal V gene usage by T lymphocytes in bronchoalveolar lavage fluid from sarcoidosis patients. Am J Respir Cell Mol Biol 14:470–477.PubMedGoogle Scholar
  219. 219.
    Striz I, Zheng L, Wang Y, et al. (1996) Soluble CD14 is increased in bronchoalveolar lavage of active sarcoidosis and correlates with alveolar macrophage membrane-bound CD 14. Am J Respir Crit Care Med 153:544–547.Google Scholar
  220. 220.
    Girgis R, Basha M, Maliarik M, et al. (1996) Cytokines in bronchoalveolar lavage fluid of patients with active pulmonary sarcoidosis. Am J Respir Crit Care Med 152:71–75.Google Scholar
  221. 221.
    Laviolette M, LaForge J, Tennina S, et al. (1991) Prognostic value of bronchalveolar lavage lymphocyte count in recently diagnosed pulmonary sarcoidosis. Chest 100:380–384.PubMedGoogle Scholar
  222. 222.
    Verstraeten A, Demedts M, Verwilghen J, et al. (1990) Predictive value of bronchoalveolar lavage in pulmonary sarcoidosis. Chest 98:560–567.PubMedGoogle Scholar
  223. 223.
    Drent M, van Velzen Blad H, Diamant M, et al. (1993) Relationship between presentation of sarcoidosis and T lymphocyte profile. A study in bronchalveolar lavage fluid. Chest 104:795–800.PubMedGoogle Scholar
  224. 224.
    Ohrn M, Skold C, van Hage Hamsten M, et al. (1995) Sarcoidosis patients have bronchial hyperreactivity and signs of mast cell activation in their bronchoalveolar lavage. Respiration 62:136–142.PubMedGoogle Scholar
  225. 225.
    Veleyre D, Saumon G, Georges R, et al. (1984) The relationship between disease duration and non-invasive pulmonary explorations in sarcoidosis with erythema nodosum. Am Rev Respir Dis 129:938–943.Google Scholar
  226. 226.
    Sartois DJ, Resnick D, Resnick C, et al. (1985) Musculoskeletal manifestations of sarcoidosis. Semin Roentgenol 4:376–386.Google Scholar
  227. 227.
    Neville E, Carstairs LS, James DG (1977) Sarcoidosis of bone. Q J Med 46:215–277.PubMedGoogle Scholar
  228. 228.
    Oven TJ, Sones M, Morrissey WL (1986) Lytic lesion of the sternum. Rare manifestations of sarcoidosis. Am J Med 80:285–287.PubMedGoogle Scholar
  229. 229.
    DeSimone DP, Brilliant HL, Basile J, et al. (1989) Granulomatous infiltration of the talus and abnormal vitamin D and calcium metabolism in a patient with sarcoidosis: Successful treatment with hydroxychloroquine. Am J Med 87:694–696.PubMedGoogle Scholar
  230. 230.
    Rahbar M, Sharma OP (1990) Hypertropic osteoarthropathy in sarcoidosis. Sarcoidosis 7:125–127.PubMedGoogle Scholar
  231. 231.
    Roberts WC, McAllister HA Jr, Ferrans VJ (1977) Sarcoidosis of the heart. A clinicopathologic study of 35 necropsy patients (group 1) and review of 78 previously described necropsy patients (group 11). Am J Med 63:86–108.PubMedGoogle Scholar
  232. 232.
    Sharma OP, Maheshwari A, Thaker K (1993) Myocardial sarcoidosis. Chest 103:253–258.PubMedGoogle Scholar
  233. 233.
    Silverman KJ, Hutchins GM, Bulkley BH (1978) Cardiac sarcoid: A clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation 58:1204–1211.PubMedGoogle Scholar
  234. 234.
    Fleming H (1994) Cardiac sarcoidosis. In James D (ed) Sarcoidosis and other granulomatous disorders. Marcel Dekker, New York, pp 323–334.Google Scholar
  235. 235.
    Ratner SJ, Fenoglio JJ, Ursell P (1986) Utility of endomyocardial biopsy in the diagnosis of cardiac sarcoidosis. Chest 90:528–533PubMedGoogle Scholar
  236. 236.
    Shammas RL, Movahed A (1993) Sarcoidosis of the heart. Clin Cardiol 16:462–472.PubMedGoogle Scholar
  237. 237.
    Fahy GJ, Marwick T, McCreery CJ, et al. (1996) Doppler echocar-diographic detection of left ventricular diastolic dysfunction in patients with pulmonary sarcoidosis. Chest 109:62–66.PubMedGoogle Scholar
  238. 238.
    Suzuki T, Kanda T, Kubota S, et al. (1994) Holter monitoring as a noninvasive indicator of cardiac involvement in sarcoidosis. Chest 106:1021–1024.PubMedGoogle Scholar
  239. 239.
    Kinney E J, Caldwell JW (1990) Do thallium myocardial perfusion scans abnormalities predict survival in sarcoid patients without cardiac symptoms? Angiology 41:573–576.PubMedGoogle Scholar
  240. 240.
    Winters SL, Cohen M, Greenberg S, et al. (1991) Sustained ventricular tachycardia associated with sarcoidosis: Assessment of the underlying cardiac anatomy and the prospective utility of programmed ventricular stimulation, drug therapy and an implantable antitachycardia device. J Am Coll Cardiol 18:937–943.PubMedGoogle Scholar
  241. 241.
    Agbogu BN, Stern BJ, Sewell C, et al. (1995) Therapeutic considerations in patients with refractory neurosarcoidosis. Arch Neurol 52:875–879.PubMedGoogle Scholar
  242. 242.
    Stern BJ, Schonfeld SA, Sewell C, et al. (1992) The treatment of neurosarcoidosis with cyclosporine. Arch Neurol 49:1065–1072.PubMedGoogle Scholar
  243. 243.
    Scott TF (1993) Neurosarcoidosis: progress and clinical aspects. Neurology 43:8–12.PubMedGoogle Scholar
  244. 244.
    Delaney P (1977) Neurologic manifestations in sarcoidosis: Review of the literature, with a report of 23 cases. Ann Intern Med 87:336–45.PubMedGoogle Scholar
  245. 245.
    Sherman JL, Stern BJ (1990) Sarcoidosis of the CNS: Comparison of unenhanced and enhanced MR images. AJR 155:1293–1301.PubMedGoogle Scholar
  246. 246.
    Zouaoui A, Maillard JC, Dormont D, et al. (1992) MRI in neurosarcoidosis. J Neuroradiol 19:271–284.PubMedGoogle Scholar
  247. 247.
    Lexa F J, Grossman RI (1994) MR of sarcoidosis in the head and spine: Spectrum of manifestations and radiographic response to steroid therapy. AJNR 15:973–82.PubMedGoogle Scholar
  248. 248.
    Seltzer S, Mark AS, Atlas SW (1992) CNS sarcoidosis: Evaluation with contrast-enhanced MR imaging. AJNR 12:1227–1233.Google Scholar
  249. 249.
    Handler MS, Johnson LM, Dick AR, et al. (1993) Neurosarcoidosis with unusual MRI findings. Neuroradiology 35:146–148.PubMedGoogle Scholar
  250. 250.
    Oksanen V (1992) Neurosarcoidosis. Semin Respir Med 13:459–467.Google Scholar
  251. 251.
    Rubenstein I, Gray TA, Moldofsky H, et al. (1988) Neurosarcoidosis associated with hypersomnolence treated with corticosteroids and brain irradiation. Chest 94:205–206.Google Scholar
  252. 252.
    Lower E, Baughman R (1995) Prolonged use of methotrexate for sarcoidosis. Arch Intern Med 155:846–851.PubMedGoogle Scholar
  253. 253.
    Maddrey WC, Johns CJ, Boitnott JK, et al. (1970) Sarcoidosis and chronic hepatic disease: a clinical and pathologic study of 20 patients. Medicine (Baltimore) 49:375–395.Google Scholar
  254. 254.
    Devaney K, Goodman ZD, Epstein MS, et al. (1993) Hepatic sarcoidosis. Clinicopathologic features in 100 patients. Am J Surg Pathol 17:1272–1280.PubMedGoogle Scholar
  255. 255.
    Rudzik C, Ishak KG, Zimmerman H J (1975) Chronic intrahepatic cholestasis of sarcoidosis. Am J Med 59:383–387.Google Scholar
  256. 256.
    Nakata K, Iwata K, Kojima K, et al. (1989) Computed tomography of liver sarcoidosis. J Comput Assist Tomogr 13:707–708.PubMedGoogle Scholar
  257. 257.
    Warshauer DM, Molina PL, Hamman SM, et al. (1995) Nodular sarcoidosis of the liver and spleen: Analysis of 32 cases. Radiology 195:757–762.PubMedGoogle Scholar
  258. 258.
    Kessler A, Mitchell DG, Israel HL, et al. (1993) Hepatic and splenic sarcoidosis: Ultrasound and MR imaging. Abdom Imaging 18:159–163.PubMedGoogle Scholar
  259. 259.
    Warshauer DM, Dumbleton SA, Molina PL, et al. (1994) Abdominal CT findings in sarcoidosis: radiologic and clinical correlation. Radiology 192:93–98.PubMedGoogle Scholar
  260. 260.
    Zisman DA, Biermann JS, Martinez FJ, et al. (1999) Sarcoidosis presenting as a tumorlike muscular lesion. Medicine 78:112–122.PubMedGoogle Scholar
  261. 261.
    Ando DG, Lynch JP, Fantone JC, III (1985) Sarcoid myopathy with elevated creatine Phosphokinase. Am Rev Respir Dis 131:298–300.PubMedGoogle Scholar
  262. 262.
    Gardner-Thorpe C (1972) Muscle weakness due to sarcoid myopathy. Six case reports and an evaluation of steroid therapy. Neurology 22:917–928.PubMedGoogle Scholar
  263. 263.
    Otake S (1994) Sarcoidosis involving skeletal muscle: Imaging findings and relative value of imaging procedures. AJR 162: 369–375.PubMedGoogle Scholar
  264. 264.
    Kurashima K, Shimizu H, Ogawa H, et al. (1991) MR and CT in the evaluation of sarcoid myopathy. J. Comp Assist Tomogr 15: 1004–1007.Google Scholar
  265. 265.
    Kobayashi H, Kotoura Y, Sakahara H, et al. (1994) Solitary muscular sarcoidosis. CT, MRI, and scintigraphic charateristics. Skeletal Radiol 23:293–295.PubMedGoogle Scholar
  266. 266.
    Fordice J, Katras T, Jackson RE, et al. (1992) Massive splenomegaly in sarcoidosis. South Med J 85:775–778.PubMedGoogle Scholar
  267. 267.
    Selroos O (1976) Sarcoidosis of the spleen. Acta Med Scand 200:337–340.PubMedGoogle Scholar
  268. 268.
    Selroos O, Koivunen E (1983) Usefulness of fine-needle aspiration biopsy of spleen in diagnosis of sarcoidosis. Chest 83:193–195.PubMedGoogle Scholar
  269. 269.
    Taavitsainen M, Koivuniemi A, Helminen J, et al. (1987) Aspiration biopsy of the spleen in patients with sarcoidosis. Acta Radiol 28:723–725.PubMedGoogle Scholar
  270. 270.
    Neiman RS (1977) Incidence and importance of splenic sarcoid-like granulomas. Arch Pathol Lab Med 101:518–521.PubMedGoogle Scholar
  271. 271.
    Kruithoff KL, Gyetko MR, Scheiman JM (1993) Giant splenomegaly and refractory hypercalcemia due to extrapulmonary sarcoidosis. Successful treatment by splenectomy. Arch Intern Med 153:2793–2796.PubMedGoogle Scholar
  272. 272.
    Salazar A, Mana J, Sala J, et al. (1994) Combined portal and pulmonary hypertension in sarcoidosis. Respiration 61:117–119.PubMedGoogle Scholar
  273. 273.
    Britt AR, Francis IR, Glazer GM, et al. (1991) Sarcoidosis: Abdominal manifestations at CT. Radiology 178:91–94.PubMedGoogle Scholar
  274. 274.
    Mathieu D, Vanderstigel M, Schaeffer A, et al. (1986) Computed tomography of splenic sarcoidosis. J Comput Assist Tomogr 10:679–680.PubMedGoogle Scholar
  275. 275.
    Warshauer DM, Semelka RC, Ascher SM (1994) Nodular sarcoidosis of the liver and spleen: Appearance on MR images. J Magn Reson Imaging 4:553–557.PubMedGoogle Scholar
  276. 276.
    Kataria Y (1980) Chlorambucil in sarcoidosis. Chest 78:36–43.PubMedGoogle Scholar
  277. 277.
    Minor RL Jr, Helmers RA (1990) Sarcoidosis and giant splenomegaly. Sarcoidosis 7:119–122.PubMedGoogle Scholar
  278. 278.
    Israel H, Fouts D, Beggs R (1973) A controlled trial of prednisone treatment of sarcoidosis. Am Rev Respir Dis 107:609–614.PubMedGoogle Scholar
  279. 279.
    Selroos O, Sellergren T (1979) Corticosteroid therapy of pulmonary sarcoidosis. A prospective evaluation of alternate day and daily dosage in stage II disease. Scand J Respir Dis 60:215–221.PubMedGoogle Scholar
  280. 280.
    Yamamoto M, Saito N, Tachibana T, et al. (1980) Effects of an 18 month corticosteroiod therapy to stage I and stage II sarcoidosis patients (control trial). In Chretien J, Marsac J, Saltiel JC (eds) Sarcoidosis and other granulomatous disorders. Pergamon Press, Paris, pp 470–474.Google Scholar
  281. 281.
    Eule H, Weinecke A, Roth I (1986) The possible influence of corticosteroid therapy on the natural course of pulmonary sarcoidosis. Ann NY Acad Sei 465:695–701.Google Scholar
  282. 282.
    Harkleroad L, Young R, Savage P, et al. (1982) Pulmonary sarcoidosis: Long-term follow-up of the effects of steroid therapy. Chest 82:84–87.PubMedGoogle Scholar
  283. 283.
    Zaki M, Lyons H, Leilop L, et al. (1987) Corticosteroid therapy in sarcoidosis. A five-year, controlled follow-up study. NY State J Med 87:496–499.Google Scholar
  284. 284.
    Lynch J, III, McCune W (1997) Immunosuppressive and cytotoxic pharmacotherapy for pulmonary disorders: State of the art. Am J Respir Crit Care Med 155:395–420.PubMedGoogle Scholar
  285. 285.
    DeRemee J (1977) The present status of treatment of pulmonary sarcoidosis: a house divided. Chest 71:388–393.PubMedGoogle Scholar
  286. 286.
    Spratling L, Tenholder F, Underwood G, et al. (1985) Daily vs alternate day predinose therapy for stage II sarcoidosis. Chest 88:687–690.PubMedGoogle Scholar
  287. 287.
    Alberts C, van der Mark T, Jansen H (1995) Inhaled budesonide in pulmonary sarcoidosis: A double-blind, placebo-controlled study. Dutch Study Group on pulmonary sarcoidosis. Eur Respir J 8:682–688.PubMedGoogle Scholar
  288. 288.
    Selroos O (1986) Use of budesonide in the treatment of pulmonary sarcoidosis. Ann NY Acad Sei 465:713–721.Google Scholar
  289. 289.
    Spiteri M, Newman S, Clarke S, et al. (1989) Inhaled corticosteroids can modulate the immunopathogenesis of pulmonary sarcoidosis. Eur Respir J 2:218–224.PubMedGoogle Scholar
  290. 290.
    Spiteri M, (1991) Inhaled corticosteroids in pulmonary sarcoidosis. Postgrad Med J 67:237–329.Google Scholar
  291. 291.
    Gupta S (1989) Treatment of sarcoidosis by steroid aerosol: A ten-year prospective study from eastern India. Sarcoidosis 6:51–54.PubMedGoogle Scholar
  292. 292.
    Zych D, Pawlicka L, Zielinski J (1993) Inhaled budesonide vs prednisone in the treatment of pulmonary sarcoidosis. Sarcoidosis 10:56–61.PubMedGoogle Scholar
  293. 293.
    du Bois RM, Greenhalgh PM, Southcott AM, et al. (1999) Randomized trial of inhaled fluticasone propionate in chronic stable pulmonary sarcoidosis: a pilot study. Eur Respir J13:1345–1350.Google Scholar
  294. 294.
    Pietinalho A, Tukiainen P, Haahtela T, et al. (1999) Oral prednisone followed by inhaled budesonide in newly diagnosed pulmonary sarcoidosis: a double-blind, placebo-controlled multicenter study. Finnish Pulmonary Sarcoidosis Study Group. Chest 116:424–431.PubMedGoogle Scholar
  295. 295.
    Baughman RP, Lower EE (1999) A clinical approach to the use of methotrexate for sarcoidosis. Thorax 54:742–746.PubMedGoogle Scholar
  296. 296.
    Baughman RP, Lower EE (1990) The effect of corticosteroid or methotrexate therapy on lung lymphocytes and macrophages in sarcoidosis. Am Rev Respir Dis 142:1268–1271.PubMedGoogle Scholar
  297. 297.
    Soriano F, Caramelli P, Nitrini R, et al. (1990) Neurosarcoidosis: Therapeutic success with methotrexate. Postgrad Med J 66:142–143.PubMedGoogle Scholar
  298. 298.
    Webster G, Razsi L, Sanchez M, et al. (1991) Weekly low-dose methotrexate therapy for cutaneous sarcoidosis. J Am Acad Dermatol 24:451–454.PubMedGoogle Scholar
  299. 299.
    Lewis SJ, Ainslie GM, Bateman ED (1999) Efficacy of azathioprine as second-line treatment in pulmonary sarcoidosis. Sarcoidosis Vase Diffuse Lung Dis 16:87–92.Google Scholar
  300. 300.
    Sharma OP (1972) Cutaneous sarcoidosis: Clinical features and management. Chest 61:320–325.PubMedGoogle Scholar
  301. 301.
    Demeter S (1988) Myocardial sarcoidosis unresponsive to steroids. Treatment with cyclophosphamide. Chest 94:202–203.PubMedGoogle Scholar
  302. 302.
    Lower EE, Broderick JP, Brott TG, et al. (1997) Diagnosis and management of neurological sarcoidosis. Arch Intern Med 157:1864–1868.PubMedGoogle Scholar
  303. 303.
    Hammond JM, Bateman ED (1990) Successful treatment of life-threatening steroid-resistant pulmonary sarcoidosis with cyclosporin in a patient with systemic lupus erythematosus. Respir Med 84:77–79.PubMedGoogle Scholar
  304. 304.
    Martinet Y, Pinkston P, Saltini C, et al. (1988) Evaluation of the in vitro and in vivo effects of cyclosporine on the lung T-lymphocyte alveolitis of active pulmonary sarcoidosis. Am Rev Respir Dis 138:1242–1248.PubMedGoogle Scholar
  305. 305.
    Wyser CP, van Schalkwyk EM, Alheit B, et al. (1997) Treatment of progressive pulmonary sarcoidosis with cyclosporin A. A randomized controlled trial. Am J Respir Crit Care Med 156:1371–1376.PubMedGoogle Scholar
  306. 306.
    Adams J, Diz M, Sharma O (1989) Effective reduction in the serum 1,25-dihydroxyvitamin D and calcium concentration in sarcoidosis-associated hypercalcemia with short-course chloroquine therapy. Ann Intern Med 111:437–438.PubMedGoogle Scholar
  307. 307.
    Jones E, Cagen J (1990) Hydroxychloroquine is effective therapy for control of cutaneous sarcoidal granulomas. Am Acad Dermatol 23:487–489.Google Scholar
  308. 308.
    Zic JA, Horowitz DH, Arzubiaga C, et al. (1991) Treatment of cutaneous sarcoidosis with chloroquine. Arch Dermatol 127:1034–1040.PubMedGoogle Scholar
  309. 309.
    Siltzbach L, Tierstein A (1964) Chloroquine therapy in 43 patients with intrathoracic and cutaneous sarcoidosis. Acta Med Scand 425:302–308.Google Scholar
  310. 310.
    British Tuberculosis Association (1967) Chloroquine in the treatment of sarcoidosis. Tubercle 48:257–272.Google Scholar
  311. 311.
    O’Leary T, Jones G, Yip A, et al. (1986) The effects of chloroquine on serum 1,25-dihydroxyvitamin D and calcium metabolism in sarcoidosis. N Engl J Med 315:727–730.PubMedGoogle Scholar
  312. 312.
    Barre PE, Gascon-Barre M, Meakins JL, et al. (1987) Hydroxychloroquine treatment of hypercalcemia in a patient with sarcoidosis undergoing hemodialysis. Am J Med 82:1259–1262.PubMedGoogle Scholar
  313. 313.
    Baltzan M, Mehta S, Kirkham TH, et al. (1999) Randomized trial of prolonged chloroquine therapy in advanced pulmonary sarcoidosis. Am J Respir Crit Care Med 160:192–197.PubMedGoogle Scholar
  314. 314.
    Quatraro A, Consoli G, Magno M, et al. (1990) Hydroxychloroquine in decompensated, treatment-refractory noninsulin-dependent diabetes mellitus. A new job for an old drug? Ann Intern Med 112:678–681.PubMedGoogle Scholar
  315. 315.
    Adams JS, Sharma OP, Diz MM, et al. (1990) Ketoconazole decreases the serum, 1,25-dihydroxyvitamin D and calcium concentration in sarcoidosis-associated hypercalcemia. J Clin Endocrinol Metab 70:1090–1095.PubMedGoogle Scholar
  316. 316.
    Ejaz AA, Zabaneh RI, Tiwari P, et al. (1994) Ketoconazole in the treatment of recurrent nephrolithiasis associated with sarcoidosis. Nephrol Dial Transplant 9:1492–1494.PubMedGoogle Scholar
  317. 317.
    Zabel P, Entzian P, Dalhoff K, et al. (1997) Pentoxifylline in treatment of sarcoidosis. Am J Respir Crit Care Med 155:1665–1669.PubMedGoogle Scholar
  318. 318.
    Carlesimo M, Giustini S, Rossi A, et al. (1995) Treatment of cutaneous and pulmonary sarcoidosis with thalidomide. J Am Acad Dermatol 32:866–869.PubMedGoogle Scholar
  319. 319.
    Nunley DR, Hattler B, Keenan RJ, et al. (1999) Lung transplantation for end-stage pulmonary sarcoidosis. Sarcoidosis Vase Diffuse Lung Dis 16:93–100.Google Scholar
  320. 320.
    Martinez F, Orens J, Deeb M, et al. (1994) Recurrence of sarcoidosis following allogeneic lung transplantation. Chest 106:1597–1599.PubMedGoogle Scholar
  321. 321.
    Johnson B, Duncan S, Ohori N, et al. (1993) Recurrence of sarcoidosis in pulmonary allograft recipients. Am Rev Respir Dis 148:1373–1377.PubMedGoogle Scholar

Copyright information

© Springer-Verlag London Limited 2001

Authors and Affiliations

  • J. P. LynchIII
  • E. A. Kazerooni

There are no affiliations available

Personalised recommendations